Matthew Keller
Stock Analyst at H.C. Wainwright
(0.04)
# 4,823
Out of 5,090 analysts
103
Total ratings
14.8%
Success rate
-30.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LABT Lakewood-Amedex Biotherapeutics | Initiated Coverage: Buy | $3 | $0.20 | +1,400.00% | 1 | Oct 28, 2026 | |
| IFRX InflaRx | Reiterated: Buy | $8 | $1.66 | +381.93% | 12 | Oct 23, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $4.56 | +295.17% | 12 | Oct 5, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $4.57 | +840.92% | 16 | Oct 5, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.04 | +2,880.77% | 13 | Sep 29, 2026 | |
| ECOR electroCore | Reiterated: Buy | $18 | $7.52 | +139.36% | 1 | Sep 21, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $0.86 | +1,527.91% | 10 | Aug 27, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterated: Hold | n/a | $0.94 | - | 6 | Aug 18, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $3.32 | +231.33% | 11 | Aug 14, 2026 | |
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $1.77 | +577.97% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.53 | +553.59% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.69 | n/a | 4 | Oct 30, 2025 |
Lakewood-Amedex Biotherapeutics
Oct 28, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.20
Upside: +1,400.00%
InflaRx
Oct 23, 2026
Reiterated: Buy
Price Target: $8
Current: $1.66
Upside: +381.93%
Gyre Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $18
Current: $4.56
Upside: +295.17%
Kyntra Bio
Oct 5, 2026
Reiterated: Buy
Price Target: $43
Current: $4.57
Upside: +840.92%
Acurx Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $31
Current: $1.04
Upside: +2,880.77%
electroCore
Sep 21, 2026
Reiterated: Buy
Price Target: $18
Current: $7.52
Upside: +139.36%
Phio Pharmaceuticals
Aug 27, 2026
Reiterated: Buy
Price Target: $14
Current: $0.86
Upside: +1,527.91%
60 Degrees Pharmaceuticals
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.94
Upside: -
Galectin Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $11
Current: $3.32
Upside: +231.33%
Seres Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $12
Current: $1.77
Upside: +577.97%
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.53
Upside: +553.59%
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $18.69
Upside: n/a